Records containing: Lymphoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2013-12-20A Phase 1 Evaluation of 64Cu-DOTA-U3-1287 in Subjects With Advanced Solid Tumors and Determination of Tumor Receptor Occupancy by U3-1287
-
CLINICAL_TRIALS study record update · 2013-12-20Lymphoma Follow-up Protocol
-
CLINICAL_TRIALS study record update · 2013-12-19A Multi-Center, Phase I, Open Label, Two Arm, Non-Randomized, Dose-Escalation, Study Of The Safety And Tolerability Of CPG 7909 In Patients Receiving Rituxan For Relapsed Or Refractory B-Cell Non-Hodgkin's Lymphoma
-
CLINICAL_TRIALS study record update · 2013-12-19Multicenter, Double-Blind, Randomized Study to Compare the Safety and Efficacy of Levofloxacin With That of Cefepime in the Treatment of Fever and Neutropenia - Phase IIIB
-
CLINICAL_TRIALS study record update · 2013-12-19Phase I Trial of High Dose Chemotherapy Using Amifostine for In-Vivo Protection of GM-CSF Primed Progenitor Cells
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2013-12-19A Phase III Clinical Trial of Immunotherapy With Humanized LL2 IgG (Epratuzumab) in Patients With Low-Grade Follicular, B-Cell Non-Hodgkin's Lymphoma Refractory to Rituxan (Rituximab)
-
CLINICAL_TRIALS study record update · 2013-12-19Non-Hodgkin's Lymphoma T Cell Protocol
-
CLINICAL_TRIALS study record update · 2013-12-19A Phase II Study to Evaluate Safety and Efficacy of Specific Immunotherapy, Recombinant Idiotype Conjugated to KLH and GM-CSF Following the Anti-CD20 Antibody, Rituximab, in Previously Treated Patients With Follicular Non-Hodgkin's Lymphoma
-
CLINICAL_TRIALS study record update · 2013-12-19A Clinicopathological Study In Burkitts's And Burkitt-Like Non-Hodgkin's Lymphoma
-
CLINICAL_TRIALS study record update · 2013-12-19A Phase 2 Open Label, Randomized, Dose And Schedule Finding, Clinical Trial Of Immunotherapy With AMG 412 In Subjects With Diffuse Large B-Cell Non-Hodgkin's Lymphoma
-
CLINICAL_TRIALS study record update · 2013-12-19An Open Label, Single-Arm Rollover Study for Subjects Who Participated In Other Romidepsin Protocols
-
CLINICAL_TRIALS study record update · 2013-12-18Reduced Intensity Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Patients With Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2013-12-18Phase I/II Study to Assess the Safety and Efficacy of Low Doses of Beta LT in Patients With B-Cell Lymphoma
-
CLINICAL_TRIALS study record update · 2013-12-18Phase III, Double-Blind, Randomized, Placebo-Controlled Trial of FavID® (Id/KLH) and GM-CSF Following CHOP/Rituximab as First-Line Therapy in Subjects With High-Intermediate and High-Risk Diffuse Large B-Cell Lymphoma
-
CLINICAL_TRIALS study record update · 2013-12-18A Phase II, Open-Label, Randomized, Multicenter Trial To Evaluate The Preliminary Safety And Efficacy of Hu1D10 In Patients With Relapsed Or Refractory Grades I, II, or III B-Cell Non-Hodgkin's Lymphoma (Including Follicular, Small Lymphocytic And Marginal Zone/MALT)
-
CLINICAL_TRIALS study record update · 2013-12-18Phase II Study of High-Dose Cytarabine, Cisplatin, and Dexamethasone Followed By Cyclophosphamide, Etoposide, Total Body Irradiation, and Autologous Bone Marrow Rescue in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
-
CLINICAL_TRIALS study record update · 2013-12-18Transplantation Using Umbilical Cord And Placental Blood
-
CLINICAL_TRIALS study record update · 2013-12-18Autologous Stem Cell Harvesting for Waldenstrom's Macroglobulinemia
-
CLINICAL_TRIALS study record update · 2013-12-18PROTOCOL FOR THE MANAGEMENT OF MYCOSIS FUNGOIDES AND THE SEZARY SYNDROME
-
CLINICAL_TRIALS study record update · 2013-12-18A Phase I Pilot Trial to Evaluate the Toxicity of Epstein-Barr Virus Specific T-Lymphocytes or Peripheral Blood Mononuclear Cells for the Treatment of Relapsed/Refractory Hodgkin's Disease
-
CLINICAL_TRIALS study record update · 2013-12-18A Multicenter Phase II Evaluation Of ONTAK (DENILEUKINDIFTITOX) In Patients With Low Or Intermediate Grade-B-Cell Non-Hodgkin's Lymphoma Who Have Been Treated Previously With A Monoclonal Antibody Or Who Are Not Candidates For Monoclonal Antibody Therapy
-
CLINICAL_TRIALS study record update · 2013-12-18A Muliticenter, Dose-Reandomized Evaluation Of Targretin Capsules Plus PUVA In Patients With Stage IB - IIA Cutaneous T-Cell Lymphoma
-
CLINICAL_TRIALS study record update · 2013-12-18National Mantle Cell Lymphoma Trial - Phase II Randomized Study of Fludarabine/Cyclophosphamide Combination With or Without Rituximab in Patients With Untreated Mantle Cell Lymphoma
-
CLINICAL_TRIALS study record update · 2013-12-18Phase I/II Study to Assess the Safety and Efficacy of Low Doses of Beta LT in Patients With Waldenstrom's Macroglobulinemia
-
CLINICAL_TRIALS study record update · 2013-12-13Phase I, Multicenter, Open Label, Dose Escalation Of 90Y-Zevalin Radioimmunotherapy Using A Modified Treatment Regimen For Relapsed Or Refractory CD20+ B-Cell (Follicular/Transformed) Non-Hodgkin's Lymphoma